Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.50
0.00 (0.00%)
At close: Oct 21, 2026

Charmacy Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
47.0946.2753.2851.3490.4723.15
Depreciation & Amortization
27.5729.4532.1726.4730.6832.03
Other Amortization
7.256.323.852.952.891.73
Loss (Gain) From Sale of Assets
0.160.18-0.31-0.05-65.84-0.15
Asset Writedown & Restructuring Costs
-0.01-0.010.36-0.01-0.01
Loss (Gain) From Sale of Investments
---0.1--0
Provision & Write-off of Bad Debts
17.9413.550.070.82.48-0.29
Other Operating Activities
47.2351.0238.1441.1636.3141.71
Change in Accounts Receivable
862.6869.57-409.63-98.17-222.47-54.81
Change in Inventory
-183.09-144.21116.04-193.35-77.7475.75
Change in Accounts Payable
-500.88202.76272.5472.25245.77-139.9
Operating Cash Flow
321.49270.89106.04-96.5444.05-19.54
Operating Cash Flow Growth
25.53%155.47%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.05-7.47-15.73-40.85-8.59-25.04
Sale of Property, Plant & Equipment
0.380.380.0880.1980.350.64
Other Investing Activities
-----0
Investing Cash Flow
-5.67-7.09-15.6439.3471.76-24.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,6703,6882,4922,8521,807
Long-Term Debt Issued
-1,4611,266836.62.26974.03
Total Debt Issued
5,1465,1314,9553,3292,8552,781
Short-Term Debt Repaid
--4,127-3,883-2,388-3,017-1,830
Long-Term Debt Repaid
--1,139-1,038-767.41-3.58-824.11
Lease Payments
-10.45-10.45-9.76-5.11-3.58-3.61
Total Debt Repaid
-5,348-5,266-4,921-3,156-3,021-2,654
Net Debt Issued (Repaid)
-202.46-135.3633.98172.72-166.48126.33
Common Dividends Paid
-110.49-80.5-64.2-75.5-28.44-52.49
Other Financing Activities
-140.281.89-1.314.043.710.56
Financing Cash Flow
-453.23-213.98-31.54101.26-191.2174.4

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.02-0.010.010.010.03-
Net Cash Flow
-137.4349.8158.8744.07-75.3730.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
315.44263.4290.31-137.3935.46-44.58
Free Cash Flow Growth
27.82%191.69%----
Free Cash Flow Margin
6.74%6.01%2.04%-3.12%0.85%-1.18%
Free Cash Flow Per Share
2.922.440.84-1.270.33-0.41
Levered Free Cash Flow
-187.23-187.13-68.5510.27-145.91-28.06
Unlevered Free Cash Flow
-153.04-151.61-30.6436.48-123.99-2.12
Free Cash Flow After Leases
304.99252.9780.54-142.4931.88-48.2

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
54.0751.7152.9858.8636.0237.42
Change in Working Capital
174.26124.1-21.53-219.31-52.94-117.74